Content - Preview

Preview of papers in the copy-editing process

These articles have been accepted for publication in Acta Dermato-Venereologica and are currently being edited and typeset. Readers should note that articles published below have been fully refereed, but have not been through the copy-editing and proof correction process. Only Abstract is possible to read. When this process is finalized the complete paper will be able to find.
CLINICAL REPORT
Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel
Guy Shalom, Meir Babaev, Khalaf Kridin, Yochai Schonmann, Amir Horev, Michal Shani, Shmuel Tiosano, Shani Fisher, Doron Comaneshter, Arnon D. Cohen
Understanding of the epidemiology and healthcare service utilization related to atopic dermatitis is necessary to inform the use of new treatments. This cross-sectional study was based on a group of patients with atopic dermatitis and a matched comparison group of enrolees without atopic dermatitis from a large medical database. Healthcare service utilization usage data were extracted and compared ...
Abstract
SHORT COMMUNICATION
Economic Analysis of Herpes Zoster in a Hospital Setting in Hong Kong
Wai-kit Ming, Wing-yin Yu, Owen Tak-yin Tsang, Paul Kay-sheung Chan, Joyce Hoi-sze You
Abstract is missing (Short communication)
Abstract
SHORT COMMUNICATION
A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation
Michihiro Kono, Masaki Sawada, Yuka Nakazawa, Tomoo Ogi, Yoshinao Muro, Masashi Akiyama
Abstract is missing (Short communication)
CLINICAL REPORT
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)
Athanasios Tsianakas, Claudia Zeidler, Claudia Riepe, Matthias Borowski, Caroline Forner, Joachim Gerss, Martin Metz, Petra Staubach, Ulrike Raap, Martin Kaatz, Marc Urban, Thomas A. Luger, Sonja Ständer
The aim of this multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II study was to determine the antipruritic effect of aprepitant vs. placebo in 58 patients with anti-histamine-refractory chronic pruritus in chronic nodular prurigo. Patients were randomized to receive either first oral aprepitant 80 mg/day or placebo for 4 weeks. Following a 2-week wash-out phase, the pa ...
SHORT COMMUNICATION
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
Lina U. Ivert, Carl-Fredrik Wahlgren, Lena Ivert, Maria Lundqvist, Maria Bradley
Abstract is missing (Short communication)
SHORT COMMUNICATION
Severe Septic Vasculitis Preceding Thoracic Empyema: Staphylococcus aureus Enterotoxin Deposition in Vessel Walls as a Possible Pathomechanism
Yasuyuki Yamaguchi, Yasuyuki Fujita, Tetsuya Ikeda, Yosuke Mai, Hajime Miyazawa, Wakana Matsumura, Toshifumi Nomura, Hiroshi Shimizu
Abstract is missing (Short communication)
REVIEW
Skin Cancer Associated Genodermatoses: A Literature Review
Juliane Schierbeck, Tine Vestergaard, Anette Bygum
Skin cancer has become the most common type of cancer worldwide as a result of environmental exposure and medical treatments. A small group of patients are genetically predisposed to skin cancer and this article is intended as a diagnostic tool when encountering patients with multiple skin cancer lesions. The disorders are described with clinical characteristics, genetics and management. The most ...
CLINICAL REPORT
Low- vs. Middle-dose Total Skin Electron Beam Therapy for Mycosis Fungoides: An Efficiency-based Retrospective Survey of Skin Response
Annelies Taverniers, Aurélie Du-Thanh, Marie Charissoux, Christine Kerr, Olivier Dereure
Optimal doses of total skin electron beam therapy for mycosis fungoides remain to be established. Clinical efficiency and adverse effects of middle-dose (25 Gy) vs. low-dose (10–12 Gy) total skin electron beam therapy were retrospectively compared in a series of 14 and 12 mycosis fungoides, respectively. Overall skin response rate was 96.2% (92.9% middle-dose and 100% low-dose; not significant ( ...
SHORT COMMUNICATION
High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen’s Disease of the Hand
Sonja Dorfer, Stefanie Kancz, Peter Birner, Katharina Strasser, Reinhard Kirnbauer, Peter Petzelbauer, Sonja Radakovic, Lucie Harpain, Hubert Pehamberger, Florian Thalhammer, Alessandra Handisurya
Abstract is missing (Short communication)
SHORT COMMUNICATION
Effect of Topical Rapamycin 1% on Multiple Trichoepitheliomas
Isabelle Dreyfus, Giuliana Onnis, Emilie Tournier, Olivier Dereure, Juliette Mazereeuw-Hautier
Abstract is missing (Short communication)
CLINICAL REPORT
Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006-2015
Niina Korhonen, Leea Ylitalo, Tiina Luukkaala, Julius Itkonen, Henni Häihälä, Juha Jernman, Erna Snellman, Johanna Palve
The incidence of cutaneous squamous cell carcinoma is increasing worldwide. In most epidemiological studies, only the first case of cutaneous squamous cell carcinoma is registered, underestimating the burden of the disease. To determine the frequency and detailed characteristics of cutaneous squamous cell carcinoma in a Finnish patient cohort, we performed a retrospective 10-year study taking into ...
SHORT COMMUNICATION
Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity
Arturo Bonometti, Jessica Gliozzo, Chiara Moltrasio, Filippo Bagnoli, Luigia Venegoni, Emanuela Passoni, Marco Paulli, Emilio Berti
Abstract is missing (Short communication)
CLINICAL REPORT
A Cost-utility Analysis of Calcipotriol/betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden
Albert Duvetorp, Lars-Åke Levin, Emma Engerstedt Mattsson, Lasse Ryttig
Psoriasis is a chronic inflammatory disorder that imposes a substantial economic burden. We conducted a cost-utility analysis from a Swedish healthcare payers perspective using a decision-tree model with a 12-week time horizon. Patients with psoriasis vulgaris could have two 4-week cycles of topical treatment with calcipotriol 50 µg/g and betamethasone 0.5 mg/g as dipropionate (Cal/BD) foam or Ca ...
CLINICAL REPORT
Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis
Maria José Tribó, Marta Turroja, Gemma Castaño-Vinyals, Antonio Bulbena, Elena Ros, Pablo García-Martínez, Francisco Tausk, Marc Sagristà, Ramon M. Pujol, Marta Ferran, Fernando Gallardo
Psoriasis is a chronic skin disease associated with considerable physical and psychological comorbidities. Stress and emotional disturbances have been implicated in both triggering the onset and exacerbation of psoriasis. In order to determine the level of perceived stress and mood alterations in patients with psoriasis and their association with disease severity, 300 individuals completed diverse ...
CLINICAL REPORT
Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study
Lina Maria Serna-Higuita, Simone L. Harrison, Petra Buttner, Margaret Glasby, Beverly A. Raasch, Angelika Iftner, Claus Garbe, Peter Martus, Thomas Iftner
Keratinocyte cancer (KC) is the most common malignancy in Caucasians. The incidence of KC has increased over the past 40 years. This case-control study investigated the environmental and host risk-factors respons­ible for development of KC in Australia’s high-risk population. Cases were immune-competent adults from Townsville, Australia (19.3°S) who had a new basal cell carcinoma (BCC) or squa ...
CLINICAL REPORT
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study
Marisol E. Otero, Juul M.P.A. van den Reek, Peter C.M. van de Kerkhof, Jorre S. Mertens, Marieke M.B. Seyger, Wietske Kievit, Elke M.G.J. de Jong
Methotrexate (MTX) and biologics are frequently used treatments for psoriasis. Exploring patients’ beliefs about their treatment may help to elucidate patients’ attitudes towards these therapies. A cross-sectional survey was conducted using the Beliefs about Medicines Questionnaire-Specific (BMQ-Specific) in patients treated with methotrexate or biologics. BMQ-Specific scores (Necessity and Co ...
REVIEW
Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics
Federico Bardazzi, Michela Starace, Francesca Bruni, Michela Magnano, Bianca Maria Piraccini, Aurora Alessandrini
Nail psoriasis affects 50–79% of patients with skin psoriasis and up to 80% of patients with psoriatic arthritis, and can also represent a negative prognostic factor in individuals with plaque psoriasis. Treatments for nail psoriasis are limited, as nails are often difficult to treat with topical therapies alone, and relapse is common. Among different systemic agents, secukinumab, a fully human ...
SHORT COMMUNICATION
Massive Localized Lymphedema, an Emerging Problem and a Challenging Pseudosarcomatous Condition Mimicking Liposarcoma
Aleksandra G. Florek, Rami Lutfi, Kenneth Wind, Wenhua Liu, Aleksandar L. Krunic
Abstract is missing (Short communication)
INVESTIGATIVE REPORT
Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
Takashi Hashimoto, Kent Sakai, Kristen M. Sanders, Gil Yosipovitch, Tasuku Akiyama
The Janus kinase 1/3 inhibitor tofacitinib has demonstrated an antipruritic effect in two phase ΙΙΙ studies in psoriasis. However, the mechanisms behind this antipruritic effect are still unknown. We presently investigated whether tofacitinib affects spontaneous itch as well as expression of itch-related cytokines and epidermal nerve fiber density (ENFD) in the imiquimod-induced mouse model of ...
INVESTIGATIVE REPORT
Usefulness of Psychiatric Intervention in a Joint Consultation for the Treatment of Burning Mouth Syndrome: A Monocentric Retrospective Study
Vinciane Le Bris, Myriam Chastaing, Martine Schollhammer, Emilie Brenaut, Laurent Misery
Primary burning mouth syndrome is a term used for chronic oral mucosal pain with no identifiable organic cause. The aim of the study was to evaluate the usefulness of a psychiatric intervention for treating burning mouth syndrome based on a joint consultation with a psychiatrist and a dermatologist. The study was proposed to all patients who visited this consultation group between 2001 and 2017 fo ...
SHORT COMMUNICATION
Progressive Nodular Histiocytosis with Large Nodules and a Bulky Mass
Takahiro Kiyohara, Kaoru Makimura, Mari Miyamoto, Takako Shijimaya, Naoko Nagano, Sei Nakamaru, Hirotsugu Tanimura
Abstract is missing (Short Communication)
BOOK REVIEW
Genetic Skin Disorders, 3rd edition
Anders Vahlquist
Abstract is missing (Book review)
BOOK REVIEW
Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 5th Edition
Regina Fölster-Holst
Abstract is missing (Book review)
BOOK REVIEW
Skin Barrier Function
Magnus Lindberg
Abstract is missing (Book review)
BOOK REVIEW
Current Problems in Dermatology, Vol. 48. Tattooed Skin and Health
Kristian Thestrup-Pedersen
Abstract is missing (Book review)
BOOK REVIEW
Chemical Immunology and Allergy, Vol. 100. History of Allergy
Carl-Fredrik Wahlgren
Abstract is missing (Book review)